Four factors impacted survival negatively: tumors larger than 5.5 cm, carcinoembryonic antigen (CEA) over 80 μg/L, surgery of the CRC primary less than 2 years before the LT, and progression of metastases at the time of LT. This evidence concerns the gene CEACAM5 and colorectal carcinoma.